Active Label Cleaning for Reliable Detection of Electron Dense Deposits in Transmission Electron Microscopy Images

Automated detection of electron dense deposits (EDD) in glomerular disease is hindered by the scarcity of high-quality labeled data. While crowdsourcing reduces annotation cost, it introduces label noise. We propose an active label cleaning method to efficiently denoise crowdsourced datasets. Our approach uses active learning to select the most valuable noisy samples for expert re-annotation, building high-accuracy cleaning models. A Label Selection Module leverages discrepancies between crowdsourced labels and model predictions for both sample selection and instance-level noise grading. Experiments show our method achieves 67.18% AP\textsubscript{50} on a private dataset, an 18.83% improvement over training on noisy labels. This performance reaches 95.79% of that with full expert annotation while reducing annotation cost by 73.30%. The method provides a practical, cost-effective solution for developing reliable medical AI with limited expert resources.

Toward Reliable and Explainable Nail Disease Classification: Leveraging Adversarial Training and Grad-CAM Visualization

Human nail diseases are gradually observed over all age groups, especially among older individuals, often going ignored until they become severe. Early detection and accurate diagnosis of such conditions are important because they sometimes reveal our body's health problems. But it is challenging due to the inferred visual differences between disease types. This paper presents a machine learning-based model for automated classification of nail diseases based on a publicly available dataset, which contains 3,835 images scaling six categories. In 224x224 pixels, all images were resized to ensure consistency. To evaluate performance, four well-known CNN models-InceptionV3, DenseNet201, EfficientNetV2, and ResNet50 were trained and analyzed. Among these, InceptionV3 outperformed the others with an accuracy of 95.57%, while DenseNet201 came next with 94.79%. To make the model stronger and less likely to make mistakes on tricky or noisy images, we used adversarial training. To help understand how the model makes decisions, we used SHAP to highlight important features in the predictions. This system could be a helpful support for doctors, making nail disease diagnosis more accurate and faster.

Fairness Under Group-Conditional Prior Probability Shift: Invariance, Drift, and Target-Aware Post-Processing

Machine learning systems are often trained and evaluated for fairness on historical data, yet deployed in environments where conditions have shifted. A particularly common form of shift occurs when the prevalence of positive outcomes changes differently across demographic groups--for example, when disease rates rise faster in one population than another, or when economic conditions affect loan default rates unequally. We study group-conditional prior probability shift (GPPS), where the label prevalence $P(Y=1\mid A=a)$ may change between training and deployment while the feature-generation process $P(X\mid Y,A)$ remains stable. Our analysis yields three main contributions. First, we prove a fundamental dichotomy: fairness criteria based on error rates (equalized odds) are structurally invariant under GPPS, while acceptance-rate criteria (demographic parity) can drift--and we prove this drift is unavoidable for non-trivial classifiers (shift-robust impossibility). Second, we show that target-domain risk and fairness metrics are identifiable without target labels: the invariance of ROC quantities under GPPS enables consistent estimation from source labels and unlabeled target data alone, with finite-sample guarantees. Third, we propose TAP-GPPS, a label-free post-processing algorithm that estimates prevalences from unlabeled data, corrects posteriors, and selects thresholds to satisfy demographic parity in the target domain. Experiments validate our theoretical predictions and demonstrate that TAP-GPPS achieves target fairness with minimal utility loss.

Food Portion Estimation: From Pixels to Calories

Reliance on images for dietary assessment is an important strategy to accurately and conveniently monitor an individual's health, making it a vital mechanism in the prevention and care of chronic diseases and obesity. However, image-based dietary assessment suffers from estimating the three dimensional size of food from 2D image inputs. Many strategies have been devised to overcome this critical limitation such as the use of auxiliary inputs like depth maps, multi-view inputs, or model-based approaches such as template matching. Deep learning also helps bridge the gap by either using monocular images or combinations of the image and the auxillary inputs to precisely predict the output portion from the image input. In this paper, we explore the different strategies employed for accurate portion estimation.

Full end-to-end diagnostic workflow automation of 3D OCT via foundation model-driven AI for retinal diseases

Optical coherence tomography (OCT) has revolutionized retinal disease diagnosis with its high-resolution and three-dimensional imaging nature, yet its full diagnostic automation in clinical practices remains constrained by multi-stage workflows and conventional single-slice single-task AI models. We present Full-process OCT-based Clinical Utility System (FOCUS), a foundation model-driven framework enabling end-to-end automation of 3D OCT retinal disease diagnosis. FOCUS sequentially performs image quality assessment with EfficientNetV2-S, followed by abnormality detection and multi-disease classification using a fine-tuned Vision Foundation Model. Crucially, FOCUS leverages a unified adaptive aggregation method to intelligently integrate 2D slices-level predictions into comprehensive 3D patient-level diagnosis. Trained and tested on 3,300 patients (40,672 slices), and externally validated on 1,345 patients (18,498 slices) across four different-tier centers and diverse OCT devices, FOCUS achieved high F1 scores for quality assessment (99.01%), abnormally detection (97.46%), and patient-level diagnosis (94.39%). Real-world validation across centers also showed stable performance (F1: 90.22%-95.24%). In human-machine comparisons, FOCUS matched expert performance in abnormality detection (F1: 95.47% vs 90.91%) and multi-disease diagnosis (F1: 93.49% vs 91.35%), while demonstrating better efficiency. FOCUS automates the image-to-diagnosis pipeline, representing a critical advance towards unmanned ophthalmology with a validated blueprint for autonomous screening to enhance population scale retinal care accessibility and efficiency.

A generalizable large-scale foundation model for musculoskeletal radiographs

Artificial intelligence (AI) has shown promise in detecting and characterizing musculoskeletal diseases from radiographs. However, most existing models remain task-specific, annotation-dependent, and limited in generalizability across diseases and anatomical regions. Although a generalizable foundation model trained on large-scale musculoskeletal radiographs is clinically needed, publicly available datasets remain limited in size and lack sufficient diversity to enable training across a wide range of musculoskeletal conditions and anatomical sites. Here, we present SKELEX, a large-scale foundation model for musculoskeletal radiographs, trained using self-supervised learning on 1.2 million diverse, condition-rich images. The model was evaluated on 12 downstream diagnostic tasks and generally outperformed baselines in fracture detection, osteoarthritis grading, and bone tumor classification. Furthermore, SKELEX demonstrated zero-shot abnormality localization, producing error maps that identified pathologic regions without task-specific training. Building on this capability, we developed an interpretable, region-guided model for predicting bone tumors, which maintained robust performance on independent external datasets and was deployed as a publicly accessible web application. Overall, SKELEX provides a scalable, label-efficient, and generalizable AI framework for musculoskeletal imaging, establishing a foundation for both clinical translation and data-efficient research in musculoskeletal radiology.

iSight: Towards expert-AI co-assessment for improved immunohistochemistry staining interpretation

Immunohistochemistry (IHC) provides information on protein expression in tissue sections and is commonly used to support pathology diagnosis and disease triage. While AI models for H\&E-stained slides show promise, their applicability to IHC is limited due to domain-specific variations. Here we introduce HPA10M, a dataset that contains 10,495,672 IHC images from the Human Protein Atlas with comprehensive metadata included, and encompasses 45 normal tissue types and 20 major cancer types. Based on HPA10M, we trained iSight, a multi-task learning framework for automated IHC staining assessment. iSight combines visual features from whole-slide images with tissue metadata through a token-level attention mechanism, simultaneously predicting staining intensity, location, quantity, tissue type, and malignancy status. On held-out data, iSight achieved 85.5\% accuracy for location, 76.6\% for intensity, and 75.7\% for quantity, outperforming fine-tuned foundation models (PLIP, CONCH) by 2.5--10.2\%. In addition, iSight demonstrates well-calibrated predictions with expected calibration errors of 0.0150-0.0408. Furthermore, in a user study with eight pathologists evaluating 200 images from two datasets, iSight outperformed initial pathologist assessments on the held-out HPA dataset (79\% vs 68\% for location, 70\% vs 57\% for intensity, 68\% vs 52\% for quantity). Inter-pathologist agreement also improved after AI assistance in both held-out HPA (Cohen's $κ$ increased from 0.63 to 0.70) and Stanford TMAD datasets (from 0.74 to 0.76), suggesting expert--AI co-assessment can improve IHC interpretation. This work establishes a foundation for AI systems that can improve IHC diagnostic accuracy and highlights the potential for integrating iSight into clinical workflows to enhance the consistency and reliability of IHC assessment.

T-LLM: Teaching Large Language Models to Forecast Time Series via Temporal Distillation

Time series forecasting plays a critical role in decision-making across many real-world applications. Unlike data in vision and language domains, time series data is inherently tied to the evolution of underlying processes and can only accumulate as real-world time progresses, limiting the effectiveness of scale-driven pretraining alone. This time-bound constraint poses a challenge for enabling large language models (LLMs) to acquire forecasting capability, as existing approaches primarily rely on representation-level alignment or inference-time temporal modules rather than explicitly teaching forecasting behavior to the LLM. We propose T-LLM, a temporal distillation framework that equips general-purpose LLMs with time series forecasting capability by transferring predictive behavior from a lightweight temporal teacher during training. The teacher combines trend modeling and frequency-domain analysis to provide structured temporal supervision, and is removed entirely at inference, leaving the LLM as the sole forecasting model. Experiments on benchmark datasets and infectious disease forecasting tasks demonstrate that T-LLM consistently outperforms existing LLM-based forecasting methods under full-shot, few-shot, and zero-shot settings, while enabling a simple and efficient deployment pipeline.

Multi-View Stenosis Classification Leveraging Transformer-Based Multiple-Instance Learning Using Real-World Clinical Data

Coronary artery stenosis is a leading cause of cardiovascular disease, diagnosed by analyzing the coronary arteries from multiple angiography views. Although numerous deep-learning models have been proposed for stenosis detection from a single angiography view, their performance heavily relies on expensive view-level annotations, which are often not readily available in hospital systems. Moreover, these models fail to capture the temporal dynamics and dependencies among multiple views, which are crucial for clinical diagnosis. To address this, we propose SegmentMIL, a transformer-based multi-view multiple-instance learning framework for patient-level stenosis classification. Trained on a real-world clinical dataset, using patient-level supervision and without any view-level annotations, SegmentMIL jointly predicts the presence of stenosis and localizes the affected anatomical region, distinguishing between the right and left coronary arteries and their respective segments. SegmentMIL obtains high performance on internal and external evaluations and outperforms both view-level models and classical MIL baselines, underscoring its potential as a clinically viable and scalable solution for coronary stenosis diagnosis. Our code is available at https://github.com/NikolaCenic/mil-stenosis.

SCOPE-PD: Explainable AI on Subjective and Clinical Objective Measurements of Parkinson's Disease for Precision Decision-Making

Parkinson's disease (PD) is a chronic and complex neurodegenerative disorder influenced by genetic, clinical, and lifestyle factors. Predicting this disease early is challenging because it depends on traditional diagnostic methods that face issues of subjectivity, which commonly delay diagnosis. Several objective analyses are currently in practice to help overcome the challenges of subjectivity; however, a proper explanation of these analyses is still lacking. While machine learning (ML) has demonstrated potential in supporting PD diagnosis, existing approaches often rely on subjective reports only and lack interpretability for individualized risk estimation. This study proposes SCOPE-PD, an explainable AI-based prediction framework, by integrating subjective and objective assessments to provide personalized health decisions. Subjective and objective clinical assessment data are collected from the Parkinson's Progression Markers Initiative (PPMI) study to construct a multimodal prediction framework. Several ML techniques are applied to these data, and the best ML model is selected to interpret the results. Model interpretability is examined using SHAP-based analysis. The Random Forest algorithm achieves the highest accuracy of 98.66 percent using combined features from both subjective and objective test data. Tremor, bradykinesia, and facial expression are identified as the top three contributing features from the MDS-UPDRS test in the prediction of PD.